Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant (Q26751404)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Predictive Factors Associated with the Reversibility of Post-transplantation Diabetes Mellitus Following Liver Transplantation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

7 April 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Chronic renal failure after transplantation of a nonrenal organ

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Perspectives on Treatment for Nonalcoholic Steatohepatitis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Changes in lipid and carbohydrate metabolism under mTOR- and calcineurin-based immunosuppressive regimen in adult patients after liver transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Risk factors of metabolic syndrome after liver transplantation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Polymorphism of Transcription Factor-7-Like 2 (TCF7L2) Gene and New-Onset Diabetes after Liver Transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Orthotopic liver transplantation in non-alcoholic fatty liver disease patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Changes in nutritional status after liver transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Alterations of the human gut microbiome in liver cirrhosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Evolving aspects of liver transplantation for nonalcoholic steatohepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Long-term medical management of the liver transplant recipient: what the primary care physician needs to know

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Approach to the patient with new-onset diabetes after transplant (NODAT).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Metabolic syndrome and liver transplantation: a review and guide to management

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Posttransplant metabolic syndrome: an epidemic waiting to happen

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

A randomized trial of exercise and dietary counseling after liver transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Guidelines for the treatment and management of new-onset diabetes after transplantation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Ten years of sirolimus therapy in orthotopic liver transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

The Diabetes Prevention Program (DPP): description of lifestyle intervention

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Mammalian target of rapamycin complex 1 is involved in differentiation of regenerating myofibers in vivo.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Weight gain and obesity after liver transplantation

31 May 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Reduction in energy expenditure after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Transmission of LDLR mutation from donor through liver transplantation resulting in hypercholesterolemia in the recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Arterial hypertension in liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Mechanisms of hypertension after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Immunosuppression impact on long-term cardiovascular complications after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Cardiovascular risk factors and immunosuppressive regimen after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Corticosteroid-free immunosuppression with daclizumab in HCV(+) liver transplant recipients: 1-year interim results of the HCV-3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Metabolic syndrome and cardiovascular risk after liver transplantation: a single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Weight gain after orthotopic liver transplantation: is nonalcoholic fatty liver disease cirrhosis a risk factor for greater weight gain?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Noninvasive characterization of graft steatosis after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

Posttransplantation weight gain is predominantly due to an increase in body fat mass.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4848946

A position statement on NAFLD/NASH based on the EASL 2009 special conference

28 November 2018

1 reference

12 December 2020

Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome

1 reference

12 December 2020

Resting energy expenditure, body composition, and dietary intake: a longitudinal study before and after liver transplantation

1 reference

12 December 2020

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary

1 reference

12 December 2020

Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation

1 reference

12 December 2020

Body composition and overweight of liver transplant recipients

1 reference

12 December 2020

Effects of cyclosporine A on skeletal muscle mitochondrial respiration and endurance time in rats

1 reference

12 December 2020

Independent effects of physical activity in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

NAFLD recurrence in liver transplant recipients

1 reference

12 December 2020

Improvement of nutritional status in malnourished cirrhotic patients one year after liver transplantation

1 reference

https://api.crossref.org/works/10.3390%2FIJMS17040490

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.3390/IJMS17040490

1 reference

2510648

2510648

1 reference

1 reference

1 reference